drospirenone has been researched along with Insulin Sensitivity in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Luisi, S; Meczekalski, B; Petraglia, F; Podfigurna, A | 1 |
| Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L | 1 |
| Bajuk Studen, K; Jensterle Sever, M; Pfeifer, M | 1 |
| Cagnacci, A; Piacenti, I; Tirelli, A; Xholli, A; Zanin, R | 1 |
| Cagnacci, A; D'Alterio, MN; Di Carlo, C; Melis, GB; Neri, M; Orrù, MM; Paoletti, AM | 1 |
| Cim, N; Gokce, AI; Yildizhan, B; Yildizhan, R | 1 |
| Baracat, EC; Consolim-Colombo, FM; Giribela, AH; Giribela, CR; Melo, NR; Moraes, TL; Nisenbaum, MG | 1 |
| Feng, GM; Huang, W; Song, Y; Wang, QS; Wang, QY; Xiao, L | 1 |
| Battaglia, C; Busacchi, P; Cianciosi, A; Facchinetti, F; Mancini, F; Persico, N | 1 |
| Cappagli, B; Gambacciani, M; Genazzani, AR; Pepe, A; Rosano, G; Vitale, C | 1 |
| Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW | 1 |
1 review(s) available for drospirenone and Insulin Sensitivity
| Article | Year |
|---|---|
Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenes; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Coronary Artery Disease; Female; Humans; Hypertension; Incretins; Insulin Resistance; Life Style; Metformin; Middle Aged; Obesity; Polycystic Ovary Syndrome; Postmenopause; Renin-Angiotensin System; Risk Factors; Sleep Apnea, Obstructive; Thiazolidinediones; Vascular Stiffness; Weight Reduction Programs | 2013 |
6 trial(s) available for drospirenone and Insulin Sensitivity
| Article | Year |
|---|---|
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult | 2018 |
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.
Topics: Adipose Tissue; Androstenes; Body Composition; Body Water; Body Weight; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Insulin Resistance; Middle Aged; Mineralocorticoid Receptor Antagonists; Norethindrone; Postmenopause; Progesterone Congeners; Quality of Life; Treatment Outcome | 2015 |
Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.
Topics: Adult; Androstenes; Blood Glucose; Blood Pressure; C-Reactive Protein; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Insulin Resistance; Longitudinal Studies; Luteinizing Hormone; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides; Waist-Hip Ratio; Young Adult | 2015 |
Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial.
Topics: Adolescent; Adult; Androstenes; Carbohydrate Metabolism; Contraceptives, Oral; Cyproterone Acetate; Female; Humans; Insulin Resistance; Life Style; Lipids; Metformin; Polycystic Ovary Syndrome; Prospective Studies | 2016 |
Clinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective study.
Topics: Androstenes; Anxiety; Blood Pressure; Depression; Estradiol; Estrogens; Fear; Female; Hormone Replacement Therapy; Humans; Insulin; Insulin Resistance; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Prospective Studies; Quality of Life; Sexual Behavior; Sleep Wake Disorders; Systole; Waist Circumference | 2011 |
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones | 2011 |
4 other study(ies) available for drospirenone and Insulin Sensitivity
| Article | Year |
|---|---|
Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone).
Topics: Adult; Androstenes; Blood Glucose; Chlormadinone Acetate; Contraceptives, Oral, Combined; Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2020 |
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women.
Topics: Adult; Androstenes; Blood Glucose; Cholesterol, HDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Triglycerides | 2014 |
Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
Topics: Adult; Aldosterone; Androstenedione; Androstenes; Blood Pressure; Body Mass Index; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Insulin Resistance; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System; Testosterone; Triglycerides | 2015 |
Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study.
Topics: Adolescent; Adult; Androstenes; Brachial Artery; Cardiovascular Diseases; Contraceptives, Oral; Endothelin-1; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Mineralocorticoid Receptor Antagonists; Obesity; Pilot Projects; Polycystic Ovary Syndrome | 2010 |